Format

Send to

Choose Destination
See comment in PubMed Commons below
Ther Umsch. 2008 Oct;65(10):593-7. doi: 10.1024/0040-5930.65.10.593.

[Coronary heart disease and dyslipdemia - dosing recommendations at beginning and end of treatment].

[Article in German]

Author information

1
Abteilung für Kardiologie, Angiologie und Pneumologie, Medizinische Klinik III, Universität Heidelberg. erwin_blessing@med.uni-heidelberg.de

Abstract

Secondary prevention in patients with coronary heart disease includes treatment with platelet inhibitors, beta-blockers, ACE inhibitors or AT (1)-blockers, and statins. Initiation of therapy generally does not require a slow gradual dose increase. In treatment naive patients with acute coronary syndromes, administration of a loading dose of aspirin and/or clopidogrel is recommended. To reduce flushing, nicotinic acid should be initiated at low stepwise increasing dosages. beta-blocker therapy should not be stopped acutely in coronary heart disease patients. If beta-blocker therapy has to be terminated, blood pressure should be monitored closely and, if necessary controlled with other medication. Termination of statin therapy in the acute phase after strokes or acute coronary syndromes is associated with increased cardiovascular events and should therefore be avoided.

PMID:
18821518
DOI:
10.1024/0040-5930.65.10.593
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center